138 related articles for article (PubMed ID: 19688212)
1. Treatment of multiple myeloma and arterial thrombosis.
Raven W; Berghout A; van Houten A; Leebeek FW
Ann Hematol; 2010 Apr; 89(4):419-20. PubMed ID: 19688212
[No Abstract] [Full Text] [Related]
2. Arterial thrombosis with immunomodulatory derivatives in the treatment of multiple myeloma: a single-center case series and review of the literature.
Martin MG; Vij R
Clin Lymphoma Myeloma; 2009 Aug; 9(4):320-3. PubMed ID: 19717384
[TBL] [Abstract][Full Text] [Related]
3. [Comparative evaluation of the effectiveness of mono- and polychemotherapy programs in patients with multiple myeloma].
Abdulkadyrov KM; Bessmel'tsev SS
Klin Med (Mosk); 1992; 70(9-10):57-60. PubMed ID: 1474818
[No Abstract] [Full Text] [Related]
4. [Development and current perspectives of treatment in multiple myeloma].
Sanz Marca A; López Alvarez J; Aboin Massieu FJ
Rev Clin Esp; 1983 Nov; 171(3):225-9. PubMed ID: 6199817
[No Abstract] [Full Text] [Related]
5. Fatal sepsis after thalidomide/dexamethasone treatment in two patients with multiple myeloma.
Wölfler A; Bauer F; Zollner G; Weber K; Sill H; Linkesch W
Haematologica; 2003 Apr; 88(4):ELT12. PubMed ID: 12681989
[No Abstract] [Full Text] [Related]
6. Bortezomib therapy following first relapse.
Orlowski RZ;
Oncology (Williston Park); 2005 Jan; 19(1):23-6. PubMed ID: 15743149
[No Abstract] [Full Text] [Related]
7. Toxic epidermal necrolysis following thalidomide and dexamethasone treatment for multiple myeloma: a case report.
Eo WK; Kim SH; Cheon SH; Lee SH; Jeong JS; Kim YS; Chang HK; Suh KS; Kim HY
Ann Hematol; 2010 Apr; 89(4):421-2. PubMed ID: 19693501
[No Abstract] [Full Text] [Related]
8. Supportive therapies in the management of myeloma.
Ludwig H;
Oncology (Williston Park); 2004 Mar; 18(3):295-6, 298. PubMed ID: 15065700
[No Abstract] [Full Text] [Related]
9. [Thalidomide in the treatment of refractory multiple myeloma: a Dutch study of 72 patients: an antitumor effect in 45%].
Wu KL; Schaafsma MR; Lokhorst HM; Wijermans PW; van der Holt B; Sonneveld P
Ned Tijdschr Geneeskd; 2002 Aug; 146(31):1445-8. PubMed ID: 12190011
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human erythropoietin and the risk of thrombosis in patients receiving thalidomide for multiple myeloma.
Galli M; Elice F; Crippa C; Comotti B; Rodeghiero F; Barbui T
Haematologica; 2004 Sep; 89(9):1141-2. PubMed ID: 15377478
[TBL] [Abstract][Full Text] [Related]
11. [Meningitis caused by Listeria monocytogenes in the patient with multiple myeloma].
Pokrovskaia OS; Mendeleeva LP; Gribanova EO; Ustinova EN; Kliasova GA; Sharikova OA; Galstian GM; Iatskov KV; Varlamova EIu; Kaplanskaia IB
Ter Arkh; 2003; 75(7):76-8. PubMed ID: 12934487
[No Abstract] [Full Text] [Related]
12. Bortezomib data show improved survival in patients with relapsed multiple myeloma.
Oncology (Williston Park); 2004 Aug; 18(9):1199, 1201. PubMed ID: 15471202
[No Abstract] [Full Text] [Related]
13. Rapid complete remission in multiple myeloma with bortezomib/thalidomide/dexamethasone combination therapy following development of tumor lysis syndrome.
Chim CS
Cancer Chemother Pharmacol; 2008 Jun; 62(1):181-2. PubMed ID: 17846773
[No Abstract] [Full Text] [Related]
14. Thalidomide plus oral melphalan for advanced multiple myeloma: a phase II study.
Offidani M; Marconi M; Corvatta L; Olivieri A; Catarini M; Leoni P
Haematologica; 2003 Dec; 88(12):1432-3. PubMed ID: 14688003
[No Abstract] [Full Text] [Related]
15. Reply. Kastritis E. et al. Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone containing regimes and the impact of novel agents. Haematologica 2007; 92:546-9.
Bergner R; Hoffmann M; Uppenkamp M
Haematologica; 2008 Jan; 93(1):e18-9. PubMed ID: 18166771
[No Abstract] [Full Text] [Related]
16. Lenalidomide (Revlimid), in combination with cyclophosphamide and dexamethasone (RCD), is an effective and tolerated regimen for myeloma patients.
Morgan GJ; Schey SA; Wu P; Srikanth M; Phekoo KJ; Jenner M; Davies FE
Br J Haematol; 2007 May; 137(3):268-9. PubMed ID: 17408469
[No Abstract] [Full Text] [Related]
17. Kappa light chain myeloma with initial cutaneous involvement.
Saka B; Erten N; Oztürk G; Yilmaz C; Dogan O; Buyukbabani N; Besisik SK
Ann Hematol; 2006 Apr; 85(4):272-4. PubMed ID: 16425024
[No Abstract] [Full Text] [Related]
18. Thalidomide and thrombosis in patients with multiple myeloma.
Camba L; Peccatori J; Pescarollo A; Tresoldi M; Corradini P; Bregni M
Haematologica; 2001 Oct; 86(10):1108-9. PubMed ID: 11602422
[No Abstract] [Full Text] [Related]
19. Comment on thalidomide usage in myeloma.
Myers B
Haematologica; 2002 Jun; 87(6):ELT29. PubMed ID: 12031937
[No Abstract] [Full Text] [Related]
20. [Multiple myeloma].
Kanoh T
Rinsho Ketsueki; 1989 Aug; 30(8):1212-5. PubMed ID: 2601036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
